Rozanolixizumab Maintains Efficacy Among Generalized Myasthenia Gravis Subgroups

[MEDPAGE TODAY]( Daily Headlines Friday, November 03, 2023 Today's Top Stories for {NAME} [MEETING COVERAGE]( [Rozanolixizumab Maintains Efficacy Among Generalized Myasthenia Gravis Subgroups]( [ONCOLOGY/HEMATOLOGY]( [Adding Atezolizumab Improves Survival in Advanced Cervical Cancer]( [AAD READING ROOM]( [Humira More Effective Against Hidradenitis Suppurativa When Combined With Surgery]( THE BREAK ROOM [Wordectomy: Guess Today’s Medical Condition]( CME SPOTLIGHT [Evidence-Based Management of Adverse Effects of Immunotherapy in Relapsed/Refractory Multiple Myeloma]( [CRITICAL CARE]( [This Antibiotic May Reduce C. Diff Risk in Pneumonia Patients]( [SPOTLIGHT ON]( [A Changing Treatment Landscape in Myasthenia Gravis]( THE BREAK ROOM [Play Today’s Wordosis]( ADVERTISEMENT [RADIOLOGY]( [Evidence of Safety, Efficacy for Salvaged Blood Irradiators Lacking, FDA Staff Say]( CME SPOTLIGHT [Evaluating the Cause of Anemia: Diagnosis and Management of Myelodysplastic Syndromes]( [MEETING COVERAGE]( [Novel C1s Inhibitor Shows Promising Activity in Rare Neurologic Disorder]( [CLINICAL CHALLENGES]( [Clinical Challenges: Discussing Childhood Vaccination With Hesitant Parents]( [CLINICAL CHALLENGES]( [Clinical Challenges: Test Your Knowledge on Cancer and Immunotherapy]( CME SPOTLIGHT [Applying the Latest Clinical Evidence to Treatment Plans for Pediatric Patients With Hodgkin Lymphoma]( [CLINICAL CHALLENGES]( [Clinical Challenges: Immunotherapy for Mutated Lung Cancer]( [MEETING COVERAGE]( [Central Vein Sign as an Imaging Biomarker of Multiple Sclerosis]( [PHARMACY]( [Pharmacist Prescribing for BP Control Makes Economic Sense]( CME SPOTLIGHT [Examining B7-H3: An Emerging Therapeutic Target for Solid Tumors]( [MEETING COVERAGE]( [Sparsentan Failed to Preserve Kidney Function Over Time in FSGS]( [ONCOLOGY/HEMATOLOGY]( [Wearables as Cancer Monitors; No China Price Break; Cancer Mystery in Appalachia]( [PUBLIC HEALTH & POLICY]( [CDC Launches Initiative to Tackle Burnout in Healthcare]( CME SPOTLIGHT [Individualizing von Willebrand Disease Treatment Strategies for Patients With Severe and Frequent Bleeds]( [CLINICAL CHALLENGES]( [Clinical Challenges: JAK Inhibitors for Atopic Dermatitis]( [OPINION]( [Transitioning Cancer Survivors Away From Oncologic Care]( [OPHTHALMOLOGY]( [What Causes Conjunctivitis? A Panoply of Pathogens, Study Shows]( CME SPOTLIGHT [Amplifying New and Emerging Clinical Evidence in the Treatment and Management of Myelodysplastic Syndrome]( [PRACTICE MANAGEMENT]( [Medicare Finalizes 3.4% Payment Cut for Physician Fees in 2024]( # Weekly Survey [Concerned About Gene-Editing Therapies?]( FDA advisors [appeared convinced]( that the benefits of a novel CRISPR therapy for sickle cell disease outweigh the theoretical risks for off-target gene editing[VOTE >]( Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [SEE ALL STORIES >]( Got a news tip? MedPage Today offers several ways to provide information to our journalists securely and confidentially. [LEARN MORE >]( [EVERYDAY HEALTH]( © 2023 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Daily_DHE?xid=nl_mpt_DHE_2023-11-03&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011